Vidipha Central Pharmaceutical Joint Stock Company (HOSE: VDP)
Health Care · Pharmaceuticals · VN
₫32,600.00
-20.20% today · -37.3% 1Y
Vidipha Central Pharmaceutical Joint Stock Company (HOSE: VDP) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $27.81M.
Over the last twelve months the share price has lost 37.3%, trading between 24.00K and 60.50K.
Tweenvest scores Vidipha Central Pharmaceutical Joint Stock Company across four factors: quality 85/100, value 71/100, dividend 100/100. Its strongest factor is dividend.
VDP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $27.81M
- Revenue (TTM)
- $37.20M
- P/E
- 11.52
- EPS
- 2,830.53
- Dividend yield
- 7.67%
- Beta (5Y)
- -0.20
- 52-week high
- ₫60,500.00
- 52-week low
- ₫24,000.00
- Avg volume (3M)
- —
- Shares outstanding
- 22.08M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| IGC Pharma, Inc.NYSEAM: IGC | $28.94M | $0.27 | -3.18% |
| Extrawell Pharmaceutical Holdings LimitedSEHK: 858 | $28.45M | HK$0.08 | -3.75% |
| ZYUS Life Sciences CorporationTSXV: ZYUS | $28.22M | CA$0.50 | -16.67% |
| Context Therapeutics Inc.NasdaqCM: CNTX | $27.95M | $0.31 | +0.79% |
| BDH Industries LimitedBSE: 524828 | $27.69M | Rs465.55 | -3.45% |
| SymBio Pharmaceuticals LimitedTSE: 4582 | $27.34M | ¥54.00 | -3.57% |
| Seach Medical Group LtdTASE: SEMG | $27.26M | ₪2.60 | -7.71% |
| Lyka Labs LimitedNSEI: LYKALABS | $27.14M | Rs72.65 | -10.91% |
Figures last refreshed Oct 11, 2026.